Mapping and predicting mortality from systemic sclerosisMuriel Elhaï, Carlos Alberto von Mühlen, Gabriela Riemekasten et al.|Annals of the Rheumatic Diseases|2017Cited by 699
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupSuzana Jordan, Thierry Zénone, Jörg H. W. Distler et al.|Annals of the Rheumatic Diseases|2014Cited by 432
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensusFrancesca Ingegnoli, Valentina Messiniti, Ariane L. Herrick et al.|Lara D. Veeken|2020Cited by 41